Lentiviral Vector Production

Accelerating your path through development to commercialization, we deliver high-quality, cost-effective and precise GMP lentiviral vector production.

Scroll Down

State-of-the-art facility

Leverage our lentivirus expertise to your advantage

From master cell bank production and expansion through to manufacture, we support you with the latest technologies from a state-of-the-art facility dedicated to the aseptic production of lentiviral vectors, helping you deliver life-changing therapeutics to patients.

Lentivirus Expertise

Greater consistency and reliability

Our lentivirus expertise highlights the expansive knowledge and technical talent of our team. This, combined with expertise in transient infection and available and scalable capacity, ensures we can accelerate your journey from bench-to-clinic and maintain reliable supply throughout.

Ensuring high product throughput and efficiency, our production platform utilizes single-use technology and optimized closed and semi-automated processes for viral vector production to deliver larger batches with greater consistency and reliability.

Simplifying and de-risking your development and scale-up

We deliver a full suite of complementary process development capabilities to support cGMP and commercial readiness, upstream and downstream process improvements, research-grade and preclinical vector production, and analytical assay development and validation from the site.

Analytical testing services, including Recombinant Competent Lentivirus (RCL) testing, vector stability testing, and safety and sterility testing, are also available.

Production Platforms

  • Adherent transient transfection
  • Suspension transient transfection

Scalable and Consistent Manufacturing

  • Roller bottles, cell stacks and fixed-bed bioreactor
  • Proprietary suspension 293T cell line for up to 200L production
  • Single-use/closed systems for virus harvest, purification and concentration
  • Access to cGMP compliant master cell banks for common cell lines including HEK293T
Get in touch

Retroviral Vector Production

We can initiate and maintain reliable supply for your early phase clinical trials and beyond, delivering high-quality, cost-effective and precise GMP master cell bank retroviral vector production and host cell expansion via producer cell lines.

Find out more

Looking for something else?